Biliary Atresia: Clinical Phenotypes and Aetiological Heterogeneity

Mark Davenport1, Ancuta Muntean1, Nedim Hadzic2

  • 1Department of Pediatric Surgery, Kings College Hospital, London SE5 9RS, UK.

Insights

Biliary atresia (BA) is a liver disease in infants causing jaundice. Its causes are diverse, with some forms linked to genetic syndromes or viral infections, while others remain unknown.

Area of Science:

  • Pediatric Gastroenterology
  • Neonatal Hepatology
  • Developmental Biology

Background:

  • Biliary atresia (BA) is a critical neonatal liver disease characterized by bile duct obstruction.
  • Presents with persistent jaundice and pale stools in early infancy.
  • BA likely represents a final common pathway for diverse etiological factors and pathogenic mechanisms, indicating significant etiological heterogeneity.

Purpose of the Study:

  • To explore the etiological heterogeneity and pathogenic mechanisms underlying biliary atresia.
  • To differentiate between syndromic and isolated forms of BA.
  • To investigate potential causative factors such as genetic predispositions and viral infections.

Main Methods:

  • Review of clinical presentations and genetic associations in BA.
  • Analysis of epidemiological data for syndromic and isolated BA cases.
  • Investigation of viral markers in perinatal infections potentially linked to BA.

Main Results:

  • BA exhibits significant etiological heterogeneity, not a single uniform disease.
  • Syndromic variants (e.g., biliary atresia splenic malformation, cat-eye syndrome) suggest early developmental origins.
  • Viral infections may play a role in perinatal BA, but the etiology of isolated BA remains largely unclear.

Conclusions:

  • Biliary atresia is a complex condition with multiple potential causes and pathways.
  • Understanding these diverse etiologies is crucial for targeted research and potential interventions.
  • Further research is needed to elucidate the pathogenesis of isolated biliary atresia.

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
86.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
300
Genetic Lingo01:11

Genetic Lingo

Overview
106.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
27
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.4K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
35.8K